Pfenex Pitches Teriparatide Pen Against Lilly's Forteo as Partner Alvogen Files In Europe

Insulin pen
Pfenex is putting its teriparatide pen up against Lilly's Forteo device in a head-to-head study • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Value Added Medicines

More from Products